5 Patents
- US124149802025Pharmaceutical Composition Comprising RUNX3 Protein and CDK4 Inhibitor or Mtor Inhibitor Cotreatment for Prevention or Treatment of Cancer
Genecraft, Inc.
0 cites - US119937832024Nucleic Acid Molecule Comprising Asymmetrically Modified ITR for Improving Expression Rate of Inserted Gene, and Use Thereof
GENECRAFT Inc.
0 cites - 0 cites
- US118916172024Modified Complex Platform of Adeno-associated Virus with Improved Rate of Expression of Loaded Genes and Reduced Genotoxicity
GENECRAFT Inc.
0 cites - US117675412023Adeno-associated Virus Complex with Improved Expression of RUNX3 Gene and Uses for Preventing or Treating KRAS Mutated Lung Cancer
GENECRAFT, Inc.
0 cites